Nutrison 800 Complete Multi Fibre

Features
  1. Suitable as a sole source of nutrition.^
  2. 0.83kcal/ml: for patients requiring lower energy diets.1-3
  3. 55g protein (27%E) per 1000ml: to meet the protein requirements of patients with low energy requirements.
  4. 15g of MF6* fibre blend per 1000ml: to help maintain normal bowel function
  5. Fish oils: providing Docosahexaenoic acid (DHA) and Eicosapentaenoic acid (EPA).
  6. Medium chain triglycerides (MCT): for easier fat digestion and absorption.4-5
  7. Whey-dominant P4 protein blend: in line with international recommendations on protein quality/amino acid profile and for gastro-intestinal tolerance benefits. 6-13
  8. Enriched with carotenoids: in line with general health recommendations for their antioxidant properties and positive effect on immune function.14
  9. 1000ml OpTri bottle: suitable for closed or open system feeding via ISO compliant flip-top screw cap.
Link copied!
Indications

For the dietary management of:

  • Disease-related malnutrition.
  • Patients with reduced energy requirements (e.g. patients who are immobile and/or have a severe neurological disorder).
Important Notice
  • Not for parenteral use.
  • Not suitable for patients requiring a fibre free diet.
  • Not suitable for patients with galactosaemia.
  • Not suitable for patients with cow’s milk protein allergy.
  • Not suitable for infants under 1 year of age.
  • Use with caution in children aged 1-12 years of age.
  • Use with caution in individuals with a seafood allergy.
Direction for Use
  • Shake well before use.
  • Use at room temperature.
  • Handle aseptically to ensure product remains sterile.
  • Usage to be determined by a healthcare professional.
Storage
  • Store in a cool, dry place.
  • Once opened, store in the refrigerator.
  • Discard unused content after 24 hours.
Order Information

Contact Nutricia Customer Care 0800 688 747

Nutrison 800 Complete Multi Fibre  Product Code  Units per carton  Pharmacode 
1000ml OpTri bottle  132379  8  2572982 
Ingredients

For the full ingredients list and nutritional information please contact Nutricia Careline on 0800 636 228

Allergen & Cultural Information
  • Contains: cow’s milk protein, soy, fish oil.
  • Halal certified.
  • No Kosher forbidden ingredients.
  • No gluten containing ingredients. No detectable gluten when tested to a sensitivity level of less than 5 parts per million (<5 ppm i.e. <5mg/kg).
  • Low lactose (lactose < 2g/100g).
References
  1. Dickerson RN et al. Measured energy expenditure of tube-fed patients with severe neurodevelopmental disabilities. J Am Coll Nutr. 1999 Feb;18(1):61-8.
  2. Dickerson RN et al. Energy requirements of non-ambulatory, tube-fed adult patients with cerebral palsy and chronic hypothermia. Nutrition. 2003 Sep;19(9):741-6.
  3. Dickerson RN et al. Validation of a new method for estimating resting energy expenditure of non-ambulatory tube-fed patients with severe neurodevelopmental disabilities. Nutrition. 2002 Jul-Aug;18(7-8):578-82.
  4. Hurt RT, McClave SA, Martindale RG, et al. Summary Points and Consensus Recommendations From the International Protein Summit. Nutrition in Clinical Practice. 2017;32:142S–151S.
  5. World Health Organization. Protein and amino acid requirements in human nutrition: report of a joint FAO/WHO/UNU expert consultation. 2007; WHO technical report series ; no. 935.
  6. Kuyumcu S, Menne D, Curcic J, et al. Noncoagulating enteral formula can empty faster from the stomach: A double-blind, randomized crossover trial using magnetic resonance imaging. Journal of Parenteral and Enteral Nutrition. 2015;39:544-551.
  7. van den Braak CC, Klebach M, Abrahamse E, et al. A novel protein mixture containing vegetable proteins renders enteral nutrition products non-coagulating after in vitro gastric digestion. Clinical Nutrition. 2013;32:765-771.
  8. Klebach M, Hofman Z, Bluemel S, et al. Effect of protein type in enteral nutritionformulas on coagulation in the stomach in vivo: Post hoc analyses of a randomized controlled trial with MRI. Abstract presented at Clinical Nutrition Week, January 16–19; Austin, Tx. Journal of Parenteral and Enteral Nutrition. 2016;40:134(21).
  9. Luttikhold J, van Norren K, Rijna H, et al. Jejunal feeding is followed by a greater rise in plasma cholecystokinin, peptide YY, glucagon-like peptide 1, and glucagon-like peptide 2 concentrations compared with gastric feeding in vivo in humans: a randomized trial. Am J Clin Nutr. 2016;103:435–43.
  10. Abrahamse E, van der Lee S, van den Braak S, et al. Gastric non-coagulation of enteral tube feed yields faster gastric emptying of protein in a dynamic in vitro model. Abstract presented at 34th ESPEN Congress. Sept 8-11; Barcelona, Spain. Clinical Nutrition Supplements. 2012;7:PP239(119).
  11. Liu J, Klebach M, Abrahamse E, et al. Specific protein mixture reduces coagulation: An in vitro stomach model study mimicking a gastric condition in critically ill patients. Poster presented at 38th ESPEN Congress. 17-20 September; Copenhagen, Denmark. Clinical Nutrition. 2016;35:MON-P182 (S220).
Additional Information

^ In accordance with Australia New Zealand Food Standards Code – Standard 2.9.5

 
# MF6 is a unique, patented blend of six soluble and insoluble fibres (soy polysaccharide, cellulose, resistant starch, gum arabic, oligofructose and inulin) reflecting the proportions of the different fibre types in a healthy diet.